Bioceltix S.A.

Warsaw Stock Exchange BCX.WA

Bioceltix S.A. Share Price on February 03, 2025: USD 20.96

Bioceltix S.A. Share Price is USD 20.96 on February 03, 2025, a -7.60% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Bioceltix S.A. 52-week high Share Price is USD 23.13 on March 13, 2024, which is 10.36% above the current Share Price.
  • Bioceltix S.A. 52-week low Share Price is USD 14.96 on June 11, 2024, which is -28.63% below the current Share Price.
  • Bioceltix S.A. average Share Price for the last 52 weeks is USD 18.77.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
SV Wall Street
Warsaw Stock Exchange: BCX.WA

Bioceltix S.A.

CEO Mr. Lukasz Bzdzion
IPO Date Nov. 8, 2021
Location Poland
Headquarters Building III
Employees 28
Sector Healthcare
Industries
Biotechnology Pet Food Pharmaceuticals
Description

Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.

StockViz Staff

February 6, 2025

Any question? Send us an email